4//SEC Filing
Martin Tami Tillotson 4
Accession 0001104659-24-028269
CIK 0001356576other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:00 PM ET
Size
9.0 KB
Accession
0001104659-24-028269
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Award
Common Stock
2024-02-23+1,250→ 87,418 total - Tax Payment
Common Stock
2024-02-23$29.06/sh−485$14,094→ 86,933 total - Disposition to Issuer
Restricted Stock Unit
2024-02-23−1,250→ 3,750 total→ Common Stock (1,250 underlying)
Footnotes (3)
- [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001539494
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:00 PM ET
- Size
- 9.0 KB